SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Momenta Pharmaceuticals, Inc. (MNTA)

MNTA RSS Feed
Add MNTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 12/2/2016 6:50:52 PM - Followers: 165 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MNTA
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MNTA News: Current Report Filing (8-k) 11/29/2016 09:09:00 AM
MNTA News: Momenta Pharmaceuticals Announces Positive Top-Line Phase 3 Results for M923, a Proposed HUMIRA® (adalimumab) Biosimilar 11/29/2016 08:00:00 AM
MNTA News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:54:01 AM
MNTA News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:47:45 AM
MNTA News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:42:27 AM
PostSubject
#16194  Sticky Note Index of posts re potential competition for generic Copaxone: DewDiligence 11/26/16 12:26:18 PM
#16211   MNTA ReadMeFirst DewDiligence 12/02/16 06:50:52 PM
#16210   If the analysts are correct and TEVA is Double_Bagel 12/02/16 04:25:55 PM
#16209   TEVA is down from $70 to $36. It DewDiligence 12/02/16 04:18:37 PM
#16208   So, nothing new here, correct? Double_Bagel 12/02/16 04:12:40 PM
#16207   What the hell does that mean? floblu14 11/29/16 04:15:17 PM
#16206   The major question remains whether the FDA will jbog 11/29/16 03:19:40 PM
#16205   Stifel reiterated a Buy rating and $20.00 price floblu14 11/29/16 02:49:04 PM
#16204   MNTA has designed around ABBV's Humira-formulation patents, according DewDiligence 11/29/16 01:54:10 PM
#16203   Momenta, AbbVie analyst commentary at Maxim jbog 11/29/16 01:46:54 PM
#16202   By sell-off I did mean to re-partner. jbog 11/29/16 11:52:47 AM
#16201   Jbog Why do you expect MNTA to sell off marthambles 11/29/16 11:44:41 AM
#16200   It's all about IP and competition. We'll see. jbog 11/29/16 11:31:15 AM
#16199   MNTA 2017-2018 News Flow DewDiligence 11/29/16 10:32:39 AM
#16198   We might go higher. marthambles 11/29/16 09:45:30 AM
#16197   15.oo premarket today. Boing x 2 11/29/16 09:30:07 AM
#16196   Momenta Pharmaceuticals Announces Positive Top-Line Phase 3 Results marthambles 11/29/16 08:08:39 AM
#16195   25 Million payment on the way. Boing x 2 11/27/16 07:09:53 AM
#16194   Index of posts re potential competition for generic Copaxone: DewDiligence 11/26/16 12:26:18 PM
#16193   I have never seen such a fierce price DewDiligence 11/26/16 12:25:12 PM
#16192   I have never seen such a fierce price alternatepatel 11/26/16 11:25:30 AM
#16191   why MNTA's generic Lovenox revenues came down from DewDiligence 11/26/16 11:07:38 AM
#16190   Hi Dew, alternatepatel 11/26/16 03:10:22 AM
#16189   Furthermore - floblu14 11/25/16 06:34:33 PM
#16188   This might be one reason the stock is floblu14 11/25/16 06:17:07 PM
#16187   Most MNTA investors need the other Lucy imnot6 11/22/16 03:36:14 PM
#16186   Same here, not alone. DFRAI 11/22/16 02:27:18 PM
#16185   like I said you don't need any technicals, tony111 11/22/16 01:51:43 PM
#16184   [OT/AVXL]—I replied in #msg-126736343, Let's not clutter the DewDiligence 11/22/16 10:49:06 AM
#16183   OT- Investment idea DFRAI 11/22/16 09:56:10 AM
#16182   Revised Point and Figure pattern. Boing x 2 11/21/16 08:46:36 PM
#16181   This is his final week (eom). DewDiligence 11/21/16 06:20:36 PM
#16180   Rick Shea's departure has taken way too long. jbog 11/21/16 06:18:08 PM
#16178   Impulse buying....it should retest 13.90 imho DFRAI 11/21/16 05:00:00 PM
#16177   We may presume that Young Kwon is no DewDiligence 11/21/16 04:36:31 PM
#16176   Interesting career post today - floblu14 11/21/16 04:28:01 PM
#16175   That's the spirit! imnot6 11/21/16 04:17:47 PM
#16174   Sorry I bought 2000 shares at 13.95, 2000 tony111 11/21/16 04:08:07 PM
#16173   MNTA is surging due to Rick Shea's pending DewDiligence 11/21/16 03:41:33 PM
#16172   Looking strong. Boing x 2 11/21/16 12:30:49 PM
#16171   Yes, because MNTA's autoimmune portfolio consists of genuinely DewDiligence 11/18/16 09:16:52 AM
#16170   Dew, also don't you think Momenta's autoimmune programs biopearl 11/18/16 09:12:51 AM
#16169   why would (M230) cause so much excitement for DewDiligence 11/18/16 08:57:26 AM
#16167   WOW - Thanks - I would venture that cpaok1 11/18/16 08:50:06 AM
#16166   No—same terms as on 20mg. DewDiligence 11/18/16 06:29:27 AM
#16165   Is the profit sharing different on the 40mg cpaok1 11/17/16 11:01:25 PM
#16163   I did not know that t57 11/17/16 08:33:28 AM
#16162   Craig Wheeler thinks M230 is the most exciting DewDiligence 11/17/16 08:25:58 AM
#16161   The FDA decision on 40mg-Copaxone might not come DewDiligence 11/17/16 08:24:34 AM
#16160   http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-publication-desi t57 11/17/16 08:06:22 AM
#16159   Sorry... Morgan stanley t57 11/17/16 06:22:41 AM
PostSubject